Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-11-19
1995-01-17
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3155
Patent
active
053825780
ABSTRACT:
The present invention provides substituted dibenzoxazepine compounds of Formula I: ##STR1## which are useful as analgesic agents for the treatment of pain, and for the treatment of convulsions and ischemia, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, and a method for eliminating or ameliorating pain and for the treatment of convulsions and ischemia, in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
REFERENCES:
patent: 788074 (1905-11-01), Hagen
patent: 813316 (1906-11-01), Hagen
patent: 3357998 (1967-12-01), Cusic
patent: 3534019 (1970-10-01), Coune
patent: 3624104 (1971-11-01), Cusic
patent: 3917649 (1975-11-01), Mueller
patent: 3989719 (1975-11-01), Mueller
patent: 3992375 (1976-11-01), Mueller
patent: 4045442 (1977-08-01), Mueller
patent: 4125532 (1978-11-01), Mueller
patent: 4170593 (1979-10-01), Mueller
patent: 4290953 (1981-09-01), Kiozumi
patent: 4379150 (1983-04-01), Ito et al.
patent: 4559336 (1985-12-01), Mueller
patent: 4559337 (1985-12-01), Mueller
patent: 4614617 (1986-09-01), Mueller
patent: 4681939 (1987-07-01), Mueller
patent: 4704386 (1987-11-01), Mueller
patent: 5180720 (1993-01-01), Husa et al.
patent: 5182272 (1993-01-01), Hallinan et al.
patent: 5212169 (1993-05-01), Husa et al.
patent: 5281590 (1994-01-01), Husa et al.
patent: 5283240 (1994-02-01), Hallinan et al.
patent: 5304644 (1994-04-01), Husa et al.
Aktan et al, Prostaglandins Leukotrienes and Essential Fatty Acids, 45 (1992), pp. 223-226.
Aktan et al, Prostaglandins Leukotrienes and Essential Fatty Acids, 49 (1993), pp. 633-641.
Tanaka et al, Arzheim.-Forsch./Drug Res., 42 (II), No. 7 (1992), pp. 945-950.
Brandenburg et al, Lancet 336 (8723), (1990), p. 1138.
A. Bennett, et al. "Antagonism of Prostanoid-Induced Contractions of Rat Gastric Fundus Muscle y SC-19220, Sodium Meclofenamate, Indomethacin or Trimethoquinol," Br. J. Pharmac., 71, 169-175 (1980)-London.
W. E. Coyne, et al. "Anticonvulsant Semicarbazides," J. Med. Chem., 11(6), 1158-1160 (1968)-USA.
Drower, et al. "The Antiociceptive Effects of Prostaglandin Antagonists in the Rat," European Journal Pharmacology, 133, 249-256 (1987)-Europe.
George, et al. "Antagonism of Alcohol Hypnosis by Blockade of Prostaglandin Synthesis and Activity: Genotype and Time Course Effects," Pharmacology Biochemistry & Behavior, vol. 19, 131-136 (1983)-USA.
R. Gimet, et al. "Quantitative Determination of Polymorphic Forms in a Formulation Matrix Using the Near Infra-Red Reflectance Analysis Technique," J. Pharmaceutical & Biomedical Analysis, vol. 5, No. 3, 205-211 (1987)-USA.
A. Gomes, et al. "Pharmacodynamics of Venom of the Centipede Scolopendra subspinipes dehaani," Indiana Journal of Experimental Biology, vol. 20, 615-618 (1982)-India.
K. Gyires, et al. "The Use of the Writhing Test in Mice for Screening Different Types of Analgesics," Arch. Int. Pharmacodyn., 267, 131-140 (1984)-USA.
D. E. MacIntyre, et al. "Antagonism of Human Platelet Responses to Stimulatory and Inhibitory Prostaglandins," Prog. Lipid. Res. 20 (1-4), 453-9 (1981)-USA.
C. A. Maggi, et al. "The Effect of SC-19220, a Prostaglandin Antagonist, on the Micturition Reflex in Rats," European Journal of Pharmacology, 152, 273-279 (1988)-Europe.
K. Nagarajan, et al. "Synthesis of 10, 11-Dihydrodibenz[b,f][1,4]oxazepine Derivatives as Potential Anticonvulsants & Psychotropic Agents," Indian Journal of Chemistry, vol. 24B, 840-844 (1985)-India.
S. Nakajyo, et al. "Inhibitory Effect of Bassianolide, A Cyclodepsipeptide, on Drug-Induced Contractions of Isolates Smooth Muscle Preparations," Japan J. Pharmacol., 32, 55-65 (1982)-Japan.
A. Rakovska, et al. "Antagonistic Effect of SC-19220 on the Responses of Guinea-Pig Gastric Muscles to Prostaglandins E.sub.1, E.sub.2 and F.sub.2, " Arch. Int. Pharmacodyn., 268, 59-69 (1984)-USA.
J. H. Sanner "Dibenzoxazepine Hydrazides as Prostaglandin Antagonists," Intra-Science Chem. Rept., vol. 6, No. 1, 1-9 (1972)-USA.
J. H. Sanner, et al. "Structure-Activity Relationships of some Dibenzoxazepine Derivatives as Prostaglandin Antagonists," Advances in the Biosciences, 9, 139-148 (1972)-USA.
Lepore, et al. Clinical and Experimental Rheumatology 9 (Suppl.6), pp. 33-35 (1991).
Waters, et al. Acta Orthop Scand. 62 (3), pp. 238-243 (1991).
Hagen Timothy J.
Hallinan E. Ann
Husa Robert K.
Datlow Philip I.
G. D. Searle & Co.
Hastreiter Roberta L.
Shah Mukund J.
Williams Roger A.
LandOfFree
Methods for treating convulsions and ischemia with substituted d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating convulsions and ischemia with substituted d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating convulsions and ischemia with substituted d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-747209